Roche

Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’
Fierce Biotech
Thu, 02/13/25 - 10:08 pm
Roche
Genentech
diversity
DEI
Donald Trump
A brain biotech launches with Roche’s spare parts
BioPharma Dive
Thu, 02/13/25 - 09:36 pm
Roche
Newleos Therapeutics
funding
mental health
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy
Yahoo Finance
Wed, 02/12/25 - 09:39 pm
Roche
Evrysdi
FDA
SMA
Ten years on, Roche jettisons InterMune and Esbriet in US
Pharmaphorum
Tue, 02/11/25 - 11:08 am
Roche
InterMune
Esbriet
IPF
M&A
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Clinical Trials Arena
Fri, 02/7/25 - 11:10 am
Roche
Genentech
clinical trials
lupus
Gazyva
FDA
Vabysmo crosses $4B mark, Polivy joins blockbuster club as Roche preps for key readouts
Fierce Pharma
Thu, 01/30/25 - 11:30 pm
Roche
Polivy
Vabysmo
earnings
Roche's breast cancer entrant Itovebi bolsters clinical profile with overall survival win
Fierce Pharma
Tue, 01/28/25 - 09:37 pm
Roche
Itovebi
breast cancer
clinical trials
Roche reports positive topline outcomes from DMD treatment trial
Clinical Trials Arena
Tue, 01/28/25 - 10:24 am
Roche
Elevidys
DMD
gene therapy
clinical trials
Roche’s new deals head tries to navigate a more ‘complicated’ and ‘expensive’ biotech world
BioPharma Dive
Thu, 01/16/25 - 09:52 pm
Roche
Boris Zaitra
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Pharma Live
Wed, 01/8/25 - 11:25 am
Roche
M&A
Poseida Therapeutics
blood cancer
Roche CEO says no plans for job cuts, business healthy, Reuters reports
MSN/TipRanks
Fri, 01/3/25 - 11:05 am
Roche
Thomas Schinecker
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
BioSpace
Thu, 01/2/25 - 11:37 am
Roche
China
antibody-drug conjugates
small cell lung cancer
Roche reports failure of Prothena-partnered Parkinson's prospect in phase 2b but highlights positives
Fierce Biotech
Thu, 12/19/24 - 10:07 am
Roche
Parkinson's Disease
clinical trials
Prothena Biosciences
Sanofi, Teva say study results show gut disease drug could be ‘best in class’
BioPharma Dive
Tue, 12/17/24 - 11:59 am
Sanofi
Teva Pharmaceutical
IBD
Merck
Roche
duvakitug
3 closely watched drugs that failed in the clinic
Pharma Voice
Mon, 12/16/24 - 11:24 am
biotech
Roche
tiragolumab
AbbVie
emraclidine
Cassava Sciences
simufilam
AbbVie to acquire Roche spinout Nimble in immune drug deal
BioPharma Dive
Fri, 12/13/24 - 11:49 am
AbbVie
Nimble Therapeutics
M&A
IL-23
Roche
Roche said it didn’t want to buy Poseida last year: A look at how the $1.5B buyout came to be
Fierce Biotech
Tue, 12/10/24 - 10:00 pm
Roche
Poseida Therapeutics
M&A
cell therapy
Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M
BioSpace
Tue, 12/3/24 - 11:23 am
Roche
Cour Pharmaceuticals
Genentech
autoimmune disease
immune tolerance platform
Roche to buy cell therapy developer Poseida for $1B
BioPharma Dive
Tue, 11/26/24 - 11:24 am
Roche
Poseida Therapeutics
M&A
cell therapy
cancer
Roche records setback in phase III study of two lung cancer drugs
MSN/Reuters
Tue, 11/26/24 - 11:17 am
Roche
anti-TIGIT
tiragolumab
Tecentriq
clnical trials
lung cancer

Pages